NCT06823726Completed
Taekwondo for Axial Spondyloarthritis
Efficacy and Safety of a 12-Week Taekwondo Training Program in Patients With Ankylosing Spondylitis and Axial Spondyloarthritis: A Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 18 Sept 2026
Brief summary (registry, in English)
The goal of this clinical trial is to learn if Taekwondo training works to help adults with ankylosing spondylitis and axial spondyloarthritis. It will also learn about the safety of Taekwondo training for these adults. The main questions are as follows: * Will Taekwondo training affect disease activity, functional improvement, and quality of life? * Will there be a difference between adults who participate in Taekwondo training and adults who continue with their usual treatment? * Is Taekwondo training safe for adults with ankylosing spondylitis and axial spondyloarthritis, and will it be an appropriate exercise for these adults? * Is there a possibility to develop a structured Taekwondo-based exercise program for adults with musculoskeletal disorders? Participants will: * Be a part of the Taekwondo training group or the control group for 12 weeks (where the control group will later participate in the same 12 week Taekwondo for comparison) * Be assessed within 2 weeks before the start of the training * Be assessed within 1 week after completing the training
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 21 (actual)
- First submitted
- 2 Feb 2025
- Start date
- 3 Feb 2025
- Primary completion date
- 29 Aug 2025
- Lead sponsor
- Wonju Severance Christian Hospital
- Diseases
- Ankylosing spondylitis
- NCT number
- NCT06823726
What you commit to
- Study type: Interventional
- Participants enrolled: 21
- From 3 Feb 2025 to the primary completion date, 29 Aug 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Major changes in medication for axial spondyloarthritis during the study period, including:
- Initiation or discontinuation of biologic agents or targeted therapies.
- Significant changes in the continued use of NSAIDs or sulfasalazine.
- Significant changes in the continued use of systemic glucocorticoids.
Other illness
- Participants will be excluded from the study if they meet any of the following conditions:
- History of orthopedic surgery or fractures within the past 12 months.
- History of cardiovascular diseases, including ischemic heart disease, cardiomyopathy, heart failure, or stroke.
- Presence of other musculoskeletal abnormalities or conditions that may limit exercise performance.
- Diagnosis of cancer within the past 5 years
Other
- Advanced ankylosis in ankylosing spondylitis, as confirmed by radiographic or CT imaging:
- \- Complete ankylosis of at least two regions of the cervical, lumbar, or thoracic spine (i.e., continuous syndesmophyte formation or complete ossification between vertebral bodies).
- Pregnancy
- Regular exercise participation within the past 6 months (defined as exercising for at least 60 minutes per session, three or more times per week).
Who the study is looking for
- Diagnosed with axial spondyloarthritis (axSpA) according to the ASAS classification criteria.
- Age: Between 19 and 59 years old.
- Stable medication or non-medication treatment:
- Patients whose medication regimen has remained stable for at least the past 3 months.
- Patients who have not taken medication for axSpA for at least the past 3 months.
Age in the registry: 19 years to 59 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Wonju Severance Christian Hospital Coordinator of this site? Confirm its status | Wŏnju | South Korea | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.